[HTML][HTML] Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Abstract The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
[HTML][HTML] Activity of convalescent and vaccine serum against a B. 1.1. 529 variant SARS-CoV-2 isolate
JM Carreño, H Alshammary, J Tcheou, G Singh… - 2021 - europepmc.org
Abstract The B. 1.1. 529 (Omicron) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was identified in November of 2021 in South Africa and Botswana as well …
2 (SARS-CoV-2) was identified in November of 2021 in South Africa and Botswana as well …
[PDF][PDF] Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, GS Johnstone Tcheou… - Nature, 2022 - researchgate.net
The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, J Tcheou, G Singh… - Nature, 2022 - ideas.repec.org
The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, J Tcheou, G Singh… - …, 2022 - ui.adsabs.harvard.edu
Abstract The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, J Tcheou, G Singh… - Nature, 2022 - econpapers.repec.org
Abstract The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
Activity of convalescent and vaccine serum against a B. 1.1. 529 variant SARS-CoV-2 isolate
JM Carreno, H Alshammary, J Tcheou, G Singh… - 2021 - pesquisa.bvsalud.org
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate |
PREPRINT-MEDRXIV loading 1 2 3 +A A -A 3.Activity of convalescent and vaccine serum …
PREPRINT-MEDRXIV loading 1 2 3 +A A -A 3.Activity of convalescent and vaccine serum …
[引用][C] Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, GS Johnstone Tcheou… - Nature, 2021 - cir.nii.ac.jp
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Activity of convalescent and vaccine serum against a B. 1.1. 529 variant SARS-CoV-2 isolate
JM Carreño, H Alshammary, J Tcheou, G Singh… - medRxiv, 2021 - medrxiv.org
The B. 1.1. 529 (Omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) was identified in November of 2021 in South Africa and Botswana as well as in a …
CoV-2) was identified in November of 2021 in South Africa and Botswana as well as in a …
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreño, H Alshammary, J Tcheou, G Singh… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …
CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in …